4-(3-Azabicyclo[3.2.2]non-3-yl)butylamine → N-[4-(3-Azabicyclo[3.2.2]non-3-yl)butyl]-6,7,8,9-tetrahydro-4-methylpyridazino[4,5-b]indolizin-1-amine
반응식
Cl[C:2]1[C:7]2[CH:8]=[C:9]3[N:14]([C:6]=2[C:5]([CH3:15])=[N:4][N:3]=1)[CH2:13][CH2:12][CH2:11][CH2:10]3.[CH:16]12[CH2:24][CH2:23][CH:20]([CH2:21][CH2:22]1)[CH2:19][N:18]([CH2:25][CH2:26][CH2:27][CH2:28][NH2:29])[CH2:17]2>>[CH:20]12[CH2:23][CH2:24][CH:16]([CH2:22][CH2:21]1)[CH2:17][N:18]([CH2:25][CH2:26][CH2:27][CH2:28][NH:29][C:2]1[N:3]=[N:4][C:5]([CH3:15])=[C:6]3[N:14]4[C:9]([CH2:10][CH2:11][CH2:12][CH2:13]4)=[CH:8][C:7]=13)[CH2:19]2참가 물질
3
실험 절차
Following the procedure in Example 9, compound XII was allowed to react with 4-(3-azabicyclo[3.2.2]non-3-yl)butylamine to give the title compound which was converted to the dihydrochloride salt: m.p.210° C. (dec.).
출처 및 근거
- ORD 기록
- ord-bee5ec45d8a545a4b5f557a978972860
- 출처 데이터셋
- uspto-grants-1998_05